St John's wort for depression--an overview and meta-analysis of randomised clinical trials
- PMID: 8704532
- PMCID: PMC2351679
- DOI: 10.1136/bmj.313.7052.253
St John's wort for depression--an overview and meta-analysis of randomised clinical trials
Abstract
Objective: To investigate if extracts of Hypericum perforatum (St John's wort) are more effective than placebo in the treatment of depression, are as effective as standard antidepressive treatment, and have fewer side effects than standard antidepressant drugs.
Design: Systematic review and meta-analysis of trials revealed by searches.
Trials: 23 randomised trials including a total of 1757 outpatients with mainly mild or moderately severe depressive disorders: 15 (14 testing single preparations and one a combination with other plant extracts) were placebo controlled, and eight (six testing single preparations and two combinations) compared hypericum with another drug treatment.
Main outcome measures: A pooled estimate of the responder rate ratio (responder rate in treatment group/responder rate in control group), and numbers of patients reporting and dropping out for side effects.
Results: Hypericum extracts were significantly superior to placebo (ratio = 2.67; 95% confidence interval 1.78 to 4.01) and similarly effective as standard antidepressants (single preparations 1.10; 0.93 to 1.31, combinations 1.52; 0.78 to 2.94). There were two (0.8%) drop outs for side effects with hypericum and seven (3.0%) with standard antidepressant drugs. Side effects occurred in 50 (19.8%) patients on hypericum and 84 (52.8%) patients on standard antidepressants.
Conclusion: There is evidence that extracts of hypericum are more effective than placebo for the treatment of mild to moderately severe depressive disorders. Further studies comparing extracts with standard antidepressants in well defined groups of patients and comparing different extracts and doses are needed.
Comment in
-
St John's wort as an antidepressant.BMJ. 1996 Aug 3;313(7052):241-2. doi: 10.1136/bmj.313.7052.241. BMJ. 1996. PMID: 8704522 Free PMC article. No abstract available.
-
St John's wort for depression.BMJ. 1996 Nov 9;313(7066):1204-5. doi: 10.1136/bmj.313.7066.1204b. BMJ. 1996. PMID: 8916765 Free PMC article. No abstract available.
-
Comparison of St John's Wort and imipramine. Finding must be treated with caution.BMJ. 2001 Feb 24;322(7284):493; author reply 494. BMJ. 2001. PMID: 11222434 No abstract available.
-
Comparison of St John's Wort and imipramine. Sensitivity of assay is questionable.BMJ. 2001 Feb 24;322(7284):493-4. BMJ. 2001. PMID: 11256367 No abstract available.
Similar articles
-
St. John's Wort (Hypericum perforatum): clinical effects on depression and other conditions.Altern Med Rev. 1998 Feb;3(1):18-26. Altern Med Rev. 1998. PMID: 9600023 Review.
-
Is St. John's wort (Hypericum perforatum) an effective antidepressant?J Nerv Ment Dis. 1998 Aug;186(8):500-1. doi: 10.1097/00005053-199808000-00008. J Nerv Ment Dis. 1998. PMID: 9717868
-
St John's wort for depression.Cochrane Database Syst Rev. 2000;(2):CD000448. doi: 10.1002/14651858.CD000448. Cochrane Database Syst Rev. 2000. Update in: Cochrane Database Syst Rev. 2005 Apr 18;(2):CD000448. doi: 10.1002/14651858.CD000448.pub2. PMID: 10796719 Updated. Review.
-
St. John's wort.Conn Med. 1998 Jan;62(1):31. Conn Med. 1998. PMID: 9509710 No abstract available.
-
St John's wort as an antidepressant.BMJ. 1996 Aug 3;313(7052):241-2. doi: 10.1136/bmj.313.7052.241. BMJ. 1996. PMID: 8704522 Free PMC article. No abstract available.
Cited by
-
Evaluation of the efficacy and safety of Yukwool-tang for major depressive disorder in women: A randomized, double blinded, placebo-controlled, parallel trial.Medicine (Baltimore). 2024 May 24;103(21):e38208. doi: 10.1097/MD.0000000000038208. Medicine (Baltimore). 2024. PMID: 38788042 Free PMC article. Clinical Trial.
-
Hyperforin ameliorates neuroinflammation and white matter lesions by regulating microglial VEGFR2 /SRC pathway in vascular cognitive impairment mice.CNS Neurosci Ther. 2024 Mar;30(3):e14666. doi: 10.1111/cns.14666. CNS Neurosci Ther. 2024. PMID: 38468126 Free PMC article.
-
Do baseline participant characteristics impact the effectiveness of a mobile health intervention for depressive symptoms? A post-hoc subgroup analysis of the CONEMO trials.Braz J Psychiatry. 2024;46:e20233172. doi: 10.47626/1516-4446-2023-3172. Epub 2024 Jan 30. Braz J Psychiatry. 2024. PMID: 38345934 Free PMC article. Clinical Trial.
-
Effect of St. John's Wort (Hypericum perforatum L.) on Male Sexual and Reproductive Health: A Narrative Review.Biomedicines. 2023 Oct 16;11(10):2800. doi: 10.3390/biomedicines11102800. Biomedicines. 2023. PMID: 37893173 Free PMC article. Review.
-
Chemical Characterization and Antioxidant Activity of Nine Hypericum Species from Greece.Antioxidants (Basel). 2023 Apr 8;12(4):899. doi: 10.3390/antiox12040899. Antioxidants (Basel). 2023. PMID: 37107274 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical